Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nbogard
    Member
    • Apr 2011
    • 10

    #1

    Contig length, k-mer coverage, and differential expression

    I'm working with some data where I have a read count and k-mer coverage (Ck) for a set of contigs and scaffolds across different conditions. I've recently heard and read a few very confusing explanations of k-mer coverage, so would appreciate some clarification. From what I gather, Ck is directly related to base coverage. But, can the size of a contig be determined if I know the Ck value, read length, and read number for that specific contig? Or would this calculation not work for a de novo transcriptome where read coverage varies greatly between contigs and scaffolds?

    For example, here are my numbers for contig A:

    Read length = 75 b
    Read count = 185,600 reads
    Ck = 63
    hash length = 31

    When I plug all this into Ck = C*(rL-k+1)/rL where C=coverage (read length*reads/contig length (cL)) and rL = read length, I get a value for cL of about 127 kb. However, when I go back to the raw data and look at that contig's sequence, I find it to be only .823 kb. Not sure how the total reads for the run figure into this, but I have ~40 million reads for this condition.

    Because C depends on the read count, my best guess is that contigs and scaffolds that have relatively high or low expression over the mean will have Ck values unrepresentative of the contig length. But I feel clueless, and my partner appears to be only acting as if he knows. I have a feeling I'm misunderstanding something completely obvious.

    Any help on this matter would be greatly appreciated.
  • diptarka
    Member
    • Mar 2013
    • 10

    #2
    Hi, all
    I am new to denovo genome assembly. I have a fastq sequence data which i have to assemble using velvet. I used the velvet optimiser script with different hash length from 27 to 41 and it predicted best to be 37. The output file contigs.fa contains 260 contigs whereas log file predicts 283 nodes, where are the rest gone? Length given in contigs.fa is in k mers? how do i calculate it's actual nucleotide length in bp?. How do i understand whether the assembly is good or bad. FInal stat given after script running:
    Final graph has 283 nodes and n50 of 347, max 2336, total 68614, using 19064/50000 reads
    Why are the number of used reads so low?

    Comment

    • mastal
      Senior Member
      • Mar 2009
      • 666

      #3
      Contig length, k-mer coverage, and differential expression

      I'm pretty sure velvet has a cutoff value for the length of the contigs
      listed in the contigs.fa file, although I don't remember off the top of my head what that is. So the missing contigs are probably the very short ones.

      The formula for calculating kmer coverage from base coverage is
      given in the velvet manual. See



      As to whether the assembly is good, have a look at this Nature Methods article entitled ''De novo genome assembly: what every biologist should know"

      Comment

      • diptarka
        Member
        • Mar 2013
        • 10

        #4
        What is the twin node as specified in velvet? It says reverse of reverse complement k merss. How are contigs actually generated using paired end assembly with velvet? can someone show using an example?

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 07:41 AM
        0 responses
        7 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        35 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Working...